CORRECTING and REPLACING Intellinetics Grows 2024 Full-Year Revenues 7%
Full-Year SaaS Revenue Grows 11%; Company made $1,625,000 in debt prepayments in 2024 COLUMBUS, Ohio–(BUSINESS WIRE)–Please replace the release with... Read more.
Pioneer Closed-End Funds Announce Postponement of March 26, 2025 Special Meeting of Stockholders
Pioneer Diversified High Income Fund, Inc. (HNW) Pioneer Floating Rate Fund, Inc. (PHD) Pioneer High Income Fund, Inc. (PHT) (each a “Fund” and together, the... Read more.
Underwood Law Says Anti-Trust Case Could Benefit Millions of Families Whose Children Participate in Competitive Cheerleading
AMARILLO, Texas–(BUSINESS WIRE)–An anti-trust lawsuit filed in U.S. District Court in Amarillo could have a nationwide impact on the millions of kids... Read more.
Pioneer Closed-End Funds Announce Postponement of March 26, 2025 Special Meeting of Stockholders
Pioneer Municipal High Income Advantage Fund, Inc. (MAV) Pioneer Municipal High Income Fund, Inc. (MHI) Pioneer Municipal High Income Opportunities Fund, Inc. (MIO)... Read more.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of The Bancorp
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In The Bancorp To Contact Him... Read more.
Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
First oral presentation of BOT/BAL neoadjuvant results from the NEOASIS trial in MSI-H and MSS solid tumors New data from the treatment-refractory hepatocellular... Read more.
Perion Announces Filing of Annual Report on Form 20-F for Fiscal Year 2024
NEW YORK & TEL AVIV, Israel–(BUSINESS WIRE)–#tech—Perion Network Ltd. (NASDAQ and TASE: PERI), a leader in advanced technology solving for... Read more.
Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025
VS-7375, a potential best-in-class oral KRAS G12D (ON/OFF) inhibitor more potent than other KRAS G12D inhibitors in preclinical models VS-7375, when combined with... Read more.
Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated... Read more.
AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025
VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation that includes preclinical... Read more.